Active, Not Recruiting Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma NCT02062827 Conditions Anaplastic Astrocytoma or Gliosarcoma, Astrocytoma, Brain Diseases, +20 more Locations University of Alabama at Birmingham — Birmingham, Alabama, United States View Trial Details
